AxoGen Inc (AXGN):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C6562)
◆英語タイトル:AxoGen Inc (AXGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6562
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥57,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥85,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among others. It also offers clinical research studies in understanding and outcome of peripheral nerve regeneration and reconstruction projects. AxoGen’s clinical research programs comprise the CHANGE study, the RANGER study, and the RECON study programs. The company provide regulations for human tissue products and medical devices. It operates distribution centers in Burleson. AxoGen is headquartered in Alachua, Florida, the US.

AxoGen Inc (AXGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AxoGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AxoGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AxoGen Inc, Medical Equipment, Deal Details 10
Equity Offering 10
AxoGen Raises USD141.4 Million in Public Offering of Shares 10
AxoGen Raises USD41 Million in Public Offering of Shares 12
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 14
AxoGen Raises USD20 Million in Public Offering of Shares 15
AxoGen Raises USD17.5 Million in Private Placement of Shares 17
AxoGen Raises USD15 Million in Public Offering of Shares 19
AxoGen Completes Underwriters’ Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For US$18.6 Million 20
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 21
AxoGen Inc – Key Competitors 22
AxoGen Inc – Key Employees 23
AxoGen Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 01, 2018: AxoGen reports 2018 second quarter financial results 25
Apr 30, 2018: AxoGen Announces 2018 First Quarter Financial Results 27
Feb 28, 2018: AxoGen Reports 2017 Fourth Quarter and Full Year Financial Results 28
Jan 08, 2018: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue 30
Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results 31
Aug 02, 2017: AxoGen Reports 2017 Second Quarter Financial Results 32
May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results 33
Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results 34
Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue 36
Corporate Communications 37
Jul 10, 2018: AxoGen Names Lisa N. Colleran As Board Director 37
Jun 04, 2018: AxoGen Names Kaila Krum Vice President, Investor Relations and Corporate Development 38
May 21, 2018: AxoGen Names Karen Zaderej As Board Chairman 39
Oct 18, 2017: AxoGen Receives David J. Gury Company of the Year Award from BioFlorida 40
Jul 17, 2017: AxoGen Appoints Jon Gingrich Chief Commercial Officer 41
Jan 05, 2017: AxoGen Appoints Ivica Ducic Medical Director 42
Product News 43
Nov 20, 2017: AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
AxoGen Inc, Medical Equipment, Key Facts, 2017 2
AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AxoGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AxoGen Inc, Deals By Market, 2012 to YTD 2018 8
AxoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AxoGen Raises USD141.4 Million in Public Offering of Shares 10
AxoGen Raises USD41 Million in Public Offering of Shares 12
AxoGen Plans to Raise up to USD92.2 Million in Public Offering of Shares 14
AxoGen Raises USD20 Million in Public Offering of Shares 15
AxoGen Raises USD17.5 Million in Private Placement of Shares 17
AxoGen Raises USD15 Million in Public Offering of Shares 19
AxoGen Completes Underwriters’ Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For US$18.6 Million 20
AxoGen Completes Second Tranche Of Private Placement For US$19 Million 21
AxoGen Inc, Key Competitors 22
AxoGen Inc, Key Employees 23
AxoGen Inc, Other Locations 24
AxoGen Inc, Subsidiaries 24

List of Figures
AxoGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AxoGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AxoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AxoGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AxoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AxoGen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ AxoGen Inc (AXGN):医療機器:M&Aディール及び事業提携情報(AxoGen Inc (AXGN) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆